Q2 2018 Holdings
Filed 2018-07-13 | 9 holdings | $320.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Crispr Therapeutics AG(CRSP) | Common Stock | H17182108 | $212.1M | 3,608,874 | 66.2% |
| Audentes Therapeutics, Inc.(BOLDEUR) | Common Stock | 05070R104 | $46.0M | 1,204,615 | 14.4% |
| Ocular Therapeutix, Inc.(OCUL) | Common Stock | 67576A100 | $15.0M | 2,215,384 | 4.7% |
| CymaBay Therapeutics, Inc.(CBAYUSD) | Common Stock | 23257D103 | $14.1M | 1,048,601 | 4.4% |
| Achaogen, Inc. | Common Stock | 004449104 | $11.1M | 1,281,152 | 3.5% |
| ImmuneDesign Corp. | Common Stock | 45252L103 | $10.0M | 2,208,210 | 3.1% |
| Second Sight Medical Products, Inc. | Common Stock | 81362J100 | $7.5M | 4,492,975 | 2.3% |
| Clovis Oncology, Inc.(CLVSEUR) | Common Stock | 189464100 | $4.6M | 101,855 | 1.4% |
| OpGen, Inc. | Common Stock | 68373L109 | $181.9K | 102,167 | 0.1% |